Quick Answer
ASTRAZENECA PLC reported R&D Expense of $14.23 billion for fiscal year 2025.
ASTRAZENECA PLC R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $14.23B | +4.8% |
| 2024 | $13.58B | +24.2% |
| 2023 | $10.94B | +12.0% |
| 2022 | $9.76B | +0.3% |
| 2021 | $9.74B | +62.5% |
| 2020 | $5.99B | -1.1% |
| 2019 | $6.06B | +2.1% |
| 2018 | $5.93B | +3.0% |
| 2017 | $5.76B | -2.3% |
| 2016 | $5.89B | -1.8% |
| 2015 | $6.00B | — |
- ASTRAZENECA PLC showed an increase of +4.8% in R&D Expense compared to the prior fiscal year.
- Over the 2015–2025 period, ASTRAZENECA PLC’s r&d expense has grown by 137.3% (from $6.00 billion to $14.23 billion).
- The most recent figure is from ASTRAZENECA PLC’s fiscal year 2025 report (Form 20-F), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: